István Puskás

HPBCD solubilized drug candidate is effective to treat prostate tumor – as published in Nature

Scientists at the University of Michigan have described a key nexus that several cancer-promoting genes depend on to drive prostate

A recent patent application of NATIONAL UNIVERSITY OF SINGAPORE claims for the treatment of lymphedema by using empty cyclodextrin (beta-cyclodextrin

On January 24-25, 2022, the FDA and Duke-Margolis Center for Health Policy will host a virtual publicworkshop on endpoint considerations

Most of the current non-pharmacological treatment strategies for atherosclerosis (AS) suffer from poor penetration into the plaque and only aim

Professor Wu Dianquing at Yale university has discovered that a widely used anticancer drug, pazopanib might be suitable for treating

Inventors Amir Farnoud and Amid Vahedi (Ohio University, US) have filed a patent application entitled “Methods for extending the shelf-life

Pfizer’s breakthrough drug candidate PF-07321332 used in combination with ritonavir was poven to successfully reduce the risk of hospitalization and

Memorial Sloan Kettering Cancer Center (MSKCC) has filed a patent application on an inhalational therapeutic composition of camostat solubilized by

This review paper shows the dominant role of the cyclodextrins in the chiral separations using capillary columns (GC, SFC, CE).

Amodiaquine is a commonly used medicament for the treatment of malarial infections. It is a 4-aminoquinoline compound similar to chloroquine